There will not be a single answer to epidermolysis bullosa. Each type of EB presents different challenges and presents a challenge to the technologies employed. The complexity of body systems affected will necessitate combination therapy, as in cancer treatment.
Our primary goal is to cure EB, that is to find a genetic fix, by correcting or replacing the genetic faults that underpin each type of EB.
However, we want to improve the lives of EB sufferers now, through the development of effective treatments that provide symptom relief and quality of life improvements. We also fund projects targeting the treatment of specific EB related health issues and developing new technologies towards treating all types of EB.
The research we fund falls into the following categories: